REGENXBIO to Host Conference Call on February 27 to Discuss Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights

Rhea-AI Summary

REGENXBIO Inc. (RGNX) will host a conference call to discuss its Q4 and full-year 2023 financial results and recent operational highlights on February 27, 2024.

ROCKVILLE, Md., Feb. 21, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Tuesday, February 27, 2024, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and full year ended December 31, 2023, and recent operational highlights.

Listeners can register for the webcast via this link. Analysts wishing to participate in the question and answer session should use this link. A replay of the webcast will be available via the company's investor website approximately two hours after the call's conclusion. Those who plan on participating are advised to join 15 minutes prior to the start time.

About REGENXBIO Inc.

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8 and AAV9. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates, including late-stage and commercial programs, in multiple therapeutic areas. REGENXBIO is committed to a "5x'25" strategy to progress five AAV Therapeutics from our internal pipeline and licensed programs into pivotal-stage or commercial products by 2025.

Contacts:
Dana Cormack
Corporate Communications
dcormack@regenxbio.com 

Investors:
Chris Brinzey
ICR Westwicke
339-970-2843
chris.brinzey@westwicke.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-host-conference-call-on-february-27-to-discuss-fourth-quarter-and-full-year-2023-financial-results-and-recent-operational-highlights-302067076.html

SOURCE REGENXBIO Inc.

FAQ

When will REGENXBIO Inc. (RGNX) host a conference call to discuss its financial results for Q4 and full-year 2023?

REGENXBIO Inc. (RGNX) will host a conference call on February 27, 2024, at 4:30 p.m. ET.

How can listeners register for the webcast of the conference call by REGENXBIO Inc. (RGNX)?

Listeners can register for the webcast via the provided link.

Where can analysts find the link to participate in the question and answer session of the conference call by REGENXBIO Inc. (RGNX)?

Analysts wishing to participate in the question and answer session should use the provided link.

When will the replay of the webcast be available for the conference call by REGENXBIO Inc. (RGNX)?

A replay of the webcast will be available via the company's investor website approximately two hours after the call's conclusion.

What is the advised time for participants to join the conference call by REGENXBIO Inc. (RGNX)?

Those who plan on participating are advised to join 15 minutes prior to the start time of the conference call.